176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.81%
Negative revenue growth while AMD stands at 6.20%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.55%
Negative gross profit growth while AMD is at 9.37%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.41%
Negative EBIT growth while AMD is at 17.30%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.41%
Negative operating income growth while AMD is at 16.14%. Joel Greenblatt would press for urgent turnaround measures.
-3.47%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-5.13%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.63%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.33%
Share count expansion well above AMD's 0.43%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.16%
Diluted share reduction more than 1.5x AMD's 0.41%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.33%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-37.95%
Negative OCF growth while AMD is at 62.09%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-42.92%
Negative FCF growth while AMD is at 73.33%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
184.00%
10Y revenue/share CAGR above 1.5x AMD's 24.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
139.27%
5Y revenue/share CAGR at 75-90% of AMD's 161.39%. Bill Ackman would encourage strategies to match competitor’s pace.
53.31%
3Y revenue/share CAGR at 50-75% of AMD's 71.72%. Martin Whitman would question if the firm lags behind competitor innovations.
15658.45%
10Y OCF/share CAGR above 1.5x AMD's 412.05%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
230.39%
Below 50% of AMD's 1449.72%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
210.79%
3Y OCF/share CAGR under 50% of AMD's 957.22%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
515.64%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
511.88%
5Y net income/share CAGR 1.25-1.5x AMD's 421.43%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
74.39%
Below 50% of AMD's 462.50%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
322.99%
10Y equity/share CAGR above 1.5x AMD's 142.69%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
157.07%
Below 50% of AMD's 912.88%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
105.96%
Below 50% of AMD's 643.67%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
90.49%
Dividend/share CAGR of 90.49% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
15.23%
3Y dividend/share CAGR of 15.23% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
15.09%
AR growth well above AMD's 5.25%. Michael Burry fears inflated revenue or higher default risk in the near future.
15.22%
Inventory growth well above AMD's 18.16%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
34.30%
Asset growth above 1.5x AMD's 12.11%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.98%
50-75% of AMD's 10.49%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
196.94%
Debt growth far above AMD's 3.77%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.41%
Our R&D shrinks while AMD invests at 6.46%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.09%
SG&A growth well above AMD's 3.57%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.